JFL Life Sciences Current Share Price | JFL Life Sciences Stock Screener
JFLLIFE
Pharmaceuticals
JFL Life Sciences Current Stock Price Today
Track the current JFL Life Sciences share price and stock price live with TickJournal's free stock screener.
Browse JFLLIFE annual financials to support your investment research.
Use the JFL Life Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
JFL Life Sciences Market Cap
₹66.98 Cr.
JFLLIFE P/E Ratio (TTM)
4.95
JFL Life Sciences P/B Ratio
0.73
EPS (TTM)
₹1.94
Dividend Yield
-
Debt to Equity
0.22
JFLLIFE 52 Week High
-
JFL Life Sciences 52 Week Low
-
Operating Margin
12.00%
Profit Margin
5.34%
JFLLIFE Revenue (TTM)
₹131.00
EBITDA
₹12.00
Net Income
₹7.00
Total Assets
₹106.00
Total Equity
₹46.00
JFL Life Sciences Current Share Price Chart
Track the current JFL Life Sciences share price and stock price with an interactive chart. Analyse JFLLIFE price trends, trading volume, historical performance, and volatility across different timeframes — the complete JFL Life Sciences stock quote in one place.
JFL Life Sciences Company Profile - Fundamental Screener
Screen JFL Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for JFLLIFE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0LA901015
JFL Life Sciences Balance Sheet Screener
Screen JFLLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 106 | 72 | 57 | 49 | 48 | 29 | 24 | 16 |
| Current Assets | 92 | 60 | 44 | 41 | 39 | 21 | 18 | 14 |
| Fixed Assets | 15 | 12 | 13 | 7 | 7 | 7 | 5 | 3 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 7 | 1 | 1 | 2 | 9 | 8 | 1 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 46 | 40 | 36 | 32 | 11 | 7 | 5 | 5 |
| Share Capital | 33 | 33 | 11 | 11 | 8 | 1 | 0 | 0 |
| Reserves & Surplus | 13 | 7 | 25 | 21 | 3 | 6 | 5 | 5 |
JFL Life Sciences Income Statement Screener - Profit & Revenue Analysis
Screen JFL Life Sciences income statement and profit fundamentals.
Analyze JFLLIFE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for JFL Life Sciences share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 131 | 131 | 82 | 47 | 45 | 35 | 33 | 30 | 32 |
| Expenses | 119 | 120 | 74 | 42 | 39 | 28 | 31 | 28 | 31 |
| EBITDA | 12 | 12 | 8 | 5 | 6 | 6 | 2 | 2 | 1 |
| Operating Profit % | 12.00% | 9.00% | 10.00% | 10.00% | 9.00% | 16.00% | 7.00% | 6.00% | 4.00% |
| Depreciation | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Profit Before Tax | 9 | 9 | 6 | 4 | 4 | 4 | 1 | 1 | 0 |
| Tax | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | 7 | 6 | 4 | 3 | 3 | 3 | 1 | 0 | 0 |
| EPS | 2.10 | 1.94 | 1.26 | 1.00 | 2.90 | 4.12 | 0.89 | 0.66 | 0.59 |
JFL Life Sciences Cash Flow Screener - Liquidity Fundamentals
Screen JFLLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | -4 | 8 | -9 | 2 | -6 | 3 | -3 |
| Investing Activities | 0 | -6 | 1 | -1 | -2 | -3 | -1 |
| Financing Activities | 4 | -2 | 8 | -2 | 7 | 0 | 4 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
JFL Life Sciences Shareholding Pattern Screener
See JFL Life Sciences shareholding pattern with promoter, FII, and DII holdings.
Check JFL Life Sciences promoter holding and ownership changes for JFLLIFE on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Sept | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 67.47% | 67.47% | 67.47% | 67.47% | 67.47% | 67.47% | 67.47% | 67.47% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 28.31% | 28.49% | 28.54% | 28.88% | 28.95% | 28.77% | 28.37% | 28.06% |
| Other Holding | 4.22% | 4.04% | 3.99% | 3.66% | 3.58% | 3.76% | 4.16% | 4.47% |
| Shareholder Count | 943 | 971 | 991 | 998 | 1,022 | 997 | 966 | 825 |
JFL Life Sciences Share Dividend Screener - Share Yield Analysis
Check JFL Life Sciences dividend history with payout and yield data.
View JFL Life Sciences dividend details including ex-dates and amounts for JFLLIFE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.25 | 1.43% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
JFL Life Sciences Stock Index Membership
See which indices include JFL Life Sciences stock.
Check JFLLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
JFL Life Sciences Market Events Screener - Corporate Actions
Get JFL Life Sciences corporate actions including splits, bonuses, and buybacks.
Check JFL Life Sciences stock events that may affect JFLLIFE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-10 | 2026-08-10 | Quarterly Result Announcement | NA | 3.02% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -4.92% |
| 2026-01-29 | 2026-01-29 | Quarterly Result Announcement | NA | -2.43% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -2.17% |
| 2025-10-28 | 2025-10-28 | Extraordinary General Meeting | NA | 1.16% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | 1.42% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 20.85% |
| 2025-04-08 | 2025-04-08 | Quarterly Result Announcement | NA | 4.52% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 26.39% |
| 2024-09-24 | 2024-09-24 | Bonus | 2:1 | 1.06% |
| 2024-09-23 | 2024-09-23 | Annual General Meeting | NA | 9.54% |
| 2024-09-13 | 2024-09-16 | Dividend | ₹ 0.25 /share | 4.68% |
JFL Life Sciences Competitors Screener - Peer Comparison
Screen JFLLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 443,925 | 36.34 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 241,351 | 83.41 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 181,321 | 85.57 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 110,344 | 23.87 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,423 | 32.76 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 100,926 | 95.29 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,044 | 30.15 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 94,132 | 25.82 | 34,145 | 5.56% | 3,503 | 53.00 |
| Mankind Pharma | 93,610 | 45.72 | 14,636 | 14.85% | 1,938 | 37.66 |
| Lupin | 93,394 | 16.93 | 29,039 | 26.75% | 5,356 | 24.64 |
JFL Life Sciences Company Announcements - News Screener
Screen JFLLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.